Robert A. Gabbay, MD, PhD, FACP has over 35 years of clinical and research experience and is Chief Medical Officer and Senior Vice President at Joslin Diabetes Center. His research focuses on improving diabetes healthcare delivery to enhance diabetes outcomes and patients’ experiences.
Dr. Gabbay, originally a native of New York City, completed his bachelor degree at McGill University and received his PhD in biochemistry from the University of Wisconsin where he studied insulin signaling mechanisms. After an Internal Medicine Residency at Cornell University - New York Hospital, he then completed a joint fellowship at Harvard Medical School and Joslin Diabetes Center, followed by a faculty position at Beth Israel Deaconess Medical Center, Harvard Medical School with Dr. Jeffrey Flier’s laboratory. He then joined the Penn State College of Medicine faculty in 1998 until 2013. While at Penn State, he founded the Penn State Institute for Diabetes and Obesity which encompassed more than 300 translational researchers and clinicians.
While in Pennsylvania, Dr. Gabbay served as faculty chair of one of the largest multi-payer patient-centered medical home (PCMH) initiatives in the country, involving more than 150 primary care practices with support from 17 payers. Since then, Dr. Gabbay has received funding from The Agency for Healthcare Research and Quality (AHRQ) as well as the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) and the Center for Medicare and Medicaid innovation (CMS) for his work around PCMH and driving improved diabetes care delivery. He also founded the state-level infrastructure for primary care transformation under AHRQ’s Infrastructure for Maintaining Primary Care Transformation (IMPaCT) program where Pennsylvania was one of four states selected to be in the development of a nationwide Primary Care Extension Program (PCEP).
Dr. Gabbay’s focus at the Joslin Diabetes Center is to foster innovation within the walls of Joslin as well as disseminate these approaches regionally, nationally, and internationally. He is dedicated to creating a model for the patient-centered medical neighborhood for diabetes, a compliment to his PCMH research. The medical neighborhood will ensure patient-centered coordinated care between the team of health professionals that are required to meet the patient’s needs. He is committed to providing the best quality possible to our diabetes patients while exceeding the highest national clinical quality measures. Through these innovative care delivery models, Joslin is committed to providing solutions to providers, health systems, payers, governmental agencies, and employers - ultimately to improve the lives of those with diabetes.